Cargando…

Bioterrorism and Biodefense

• Bioterrorism continues to pose a global threat due to ongoing geopolitical conflicts. • Early recognition of bioterrorism is critical to preserving individual and public health. Agents of bioterrorism concern are prioritized according to their potential to cause high mortality and major impact on...

Descripción completa

Detalles Bibliográficos
Autor principal: Artenstein, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150309/
http://dx.doi.org/10.1016/B978-0-7020-6285-8.00075-7
_version_ 1783521000650964992
author Artenstein, Andrew W.
author_facet Artenstein, Andrew W.
author_sort Artenstein, Andrew W.
collection PubMed
description • Bioterrorism continues to pose a global threat due to ongoing geopolitical conflicts. • Early recognition of bioterrorism is critical to preserving individual and public health. Agents of bioterrorism concern are prioritized according to their potential to cause high mortality and major impact on public health (category A); to be associated with moderate morbidity (category B); or to represent emerging threats and future concerns (category C). • Clinical syndromes caused by agents of bioterrorism must be differentiated from those due to other, naturally occurring infectious diseases. • Biodefense represents the range of public health responses that can prevent or mitigate the effects of bioterrorism and of outbreaks of naturally occurring, emerging infectious diseases.
format Online
Article
Text
id pubmed-7150309
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-71503092020-04-13 Bioterrorism and Biodefense Artenstein, Andrew W. Infectious Diseases Article • Bioterrorism continues to pose a global threat due to ongoing geopolitical conflicts. • Early recognition of bioterrorism is critical to preserving individual and public health. Agents of bioterrorism concern are prioritized according to their potential to cause high mortality and major impact on public health (category A); to be associated with moderate morbidity (category B); or to represent emerging threats and future concerns (category C). • Clinical syndromes caused by agents of bioterrorism must be differentiated from those due to other, naturally occurring infectious diseases. • Biodefense represents the range of public health responses that can prevent or mitigate the effects of bioterrorism and of outbreaks of naturally occurring, emerging infectious diseases. 2017 2016-08-12 /pmc/articles/PMC7150309/ http://dx.doi.org/10.1016/B978-0-7020-6285-8.00075-7 Text en Copyright © 2017 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Artenstein, Andrew W.
Bioterrorism and Biodefense
title Bioterrorism and Biodefense
title_full Bioterrorism and Biodefense
title_fullStr Bioterrorism and Biodefense
title_full_unstemmed Bioterrorism and Biodefense
title_short Bioterrorism and Biodefense
title_sort bioterrorism and biodefense
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150309/
http://dx.doi.org/10.1016/B978-0-7020-6285-8.00075-7
work_keys_str_mv AT artensteinandreww bioterrorismandbiodefense